Anurag K. Singh - Concepedia

Author

Anurag K. Singh

University of Kansas Medical Center ORCID

Also Known As

A K Singh, A Singh, A. K. Singh, A. Singh, Alok Kumar Singh, Anurag K Singh, Anurag K. Singh, Anurag Kumar Singh, Anurag Singh, Anurag Singh -

176

Publications

2.4K

Citations

H-Index

Concepts

All Affiliations

University of Kansas Medical Center Dana-Farber Cancer Institute Moffitt Cancer Center University of Kansas Memorial Sloan Kettering Cancer Center

About

Anurag K. Singh is an author at University of Kansas Medical Center specializing in medicine, transplantation, and cell transplantation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	14	707
2	Health Sciences	3	3	261
3	Engineering	1	1	16
4	Public Health	1	1	54
5	Biomedical Engineering	1	1	55

Anurag K. Singh

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Predictors of radiation-induced esophageal toxicity in patients with non-small-cell lung cancer treated with three-dimensional conformal radiotherapy Anurag K. Singh, Mary Ann Lockett, Jeffrey D. Bradley International Journal of Radiation OncologyBiologyPhysics Esophageal CancerNon-small-cell Lung CancerRadiation TherapyThree-dimensional Conformal RadiotherapyMedicine	2003	196
Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of <i>FLT3</i> Mark J. Levis, Mehdi Hamadani, Brent R. Logan, Journal of Clinical Oncology	2024	153
Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remission Armin Rashidi, Mehdi Hamadani, Mei-Jie Zhang, Blood Advances	2019	127
Allogeneic transplantation after PD-1 blockade for classic Hodgkin lymphoma Reid W. Merryman, Luca Castagna, Laura Giordano, Leukemia Lymphoid NeoplasiaTransplantationMedicineImmunologyBlood Transplantation	2021	77
Reduced Risk of Cytomegalovirus Infection in Solid Organ Transplant Recipients Treated With Sirolimus: A Pooled Analysis of Clinical Trials Laura A. Demopoulos, Martin S. Polinsky, George H. Steele, Transplantation Proceedings Cytomegalovirus InfectionTransplantationSolid Organ TransplantationImmunologyClinical Trials	2008	76
A Phase I Study to Evaluate Two Doses of Wharton’s Jelly-Derived Mesenchymal Stromal Cells for the Treatment of De Novo High-Risk or Steroid-Refractory Acute Graft Versus Host Disease Rupal P. Soder, Buddhadeb Dawn, Mark L. Weiss, Stem Cell Reviews and Reports Regenerative MedicineCell TherapyTransplantationMedicineStem Cell Transplantation	2020	55
Impact of SARS-CoV-2 in Hematopoietic Stem Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy Recipients Muhammad Umair Mushtaq, Moazzam Shahzad, Sibgha Gull Chaudhary, Transplantation and Cellular Therapy Cell TherapyImmunologyTransplantation MedicineCovid-19 EpidemiologyImmunotherapy	2021	54
Autologous stem cell transplantation after anti-PD-1 therapy for multiply relapsed or refractory Hodgkin lymphoma Reid W. Merryman, Robert Redd, Taiga Nishihori, Blood Advances Cell TherapyAnti-pd-1 TherapyRelapsed/refractory Hodgkin LymphomaImmunologyImmunotherapy	2021	45
Post-Transplantation Cyclophosphamide Is Associated with an Increase in Non-Cytomegalovirus Herpesvirus Infections in Patients with Acute Leukemia and Myelodysplastic Syndrome Anurag K. Singh, Christopher E. Dandoy, Min Chen, Transplantation and Cellular Therapy	2021	42
Allogeneic blood or marrow transplantation with haploidentical donor and post-transplantation cyclophosphamide in patients with myelofibrosis: a multicenter study Siddharth Kunte, Lisa Rybicki, Auro Viswabandya, Leukemia TransplantationMarrow TransplantationBone Marrow FailureStem Cell TransplantationTransplantation Medicine	2021	40

Page 1